The significance of autoantibodies and immunoglobulins in acute liver failure: A cohort study
- 11 June 2007
- journal article
- Published by Elsevier
- Vol. 47 (5) , 664-670
- https://doi.org/10.1016/j.jhep.2007.05.011
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Outcomes Following Liver Transplantation for Seronegative Acute Liver Failure: Experience During a 12-Year Period With More Than 100 PatientsLiver Transplantation, 2004
- Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flowJournal of Hepatology, 2004
- Infection and the progression of hepatic encephalopathy in acute liver failureGastroenterology, 2003
- Circulating acute phase cytokines and cytokine inhibitors in fulminant hepatic failure: associations with mortality and haemodynamicsClinical Intensive Care, 2001
- The systemic inflammatory response syndrome in acute liver failureHepatology, 2000
- Tumor necrosis factor α in the pathogenesis of human and murine fulminant hepatic failureGastroenterology, 2000
- Acute Sporadic Non–A, Non–B, Non–C, Non–D, Non–E HepatitisHepatology, 1997
- Late-onset hepatic failure: clinical features, serology and outcome following transplantationJournal of Hepatology, 1995
- Circulating proinflammatory cytokines (IL-1β, TNF-α, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitisClinical and Experimental Immunology, 1994
- Late Onset Hepatic Failure: Clinical, Serological and Histological FeaturesHepatology, 1986